Product Reports Resources Pricing Login Book a demo

BeOne Medicines

Biotech & Life Sciences · Dongcheng District, China · Founded 2010 · IPO 2016

Innovative oncology therapeutics for global cancer care accessibility, formerly BeiGene

Valuation $32B
Revenue $6.51B
EBITDA $1.01B

Investors

3 investors on BeOne Medicines's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage
Hillhouse Capital
CITIC Capital
Series B+ 1 investor entered at this stage
Rock Springs Capital

Global footprint

Where BeOne Medicines has talent and traffic

Workforce by country
41 countries with
team presence
🇨🇳 China36.1%
🇺🇸 United States31.9%
🇦🇺 Australia6%
🇨🇭 Switzerland4.5%
🇫🇷 France2.4%
Top 5 of 41 shown
Web traffic by country
53K monthly visits
across markets
🇺🇸 United States39.8%
🇬🇧 United Kingdom14.9%
🏳️ Korea6.4%
🏳️ Republic of5.5%
🇮🇳 India3.4%
Top 5 markets shown

Talent graph

The shape of BeOne Medicines's talent

Dealroom maps BeOne Medicines's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

7 standout operatorsDealroom-flagged across the org
11 AI specialistsincl. 2 core researchers
3,529 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock BeOne Medicines's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$228M patent portfolio · 433 active families

Estimated portfolio value
$228M
0.72% of market cap · 2.1× smaller than top peer Genmab ($488M)
433 active patent families
Where BeOne Medicines innovates Antiendomysial antibodiesAntigen Binding FragmentCancer researchCarcinosisDisease

Where BeOne Medicines concentrates vs peers

Each axis is a top-10 topic across BeOne Medicines and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

BeOne Medicines's 5 investments and acquisitions.

Every disclosed deal where BeOne Medicines appeared as a backer or acquirer, 2021–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across BeOne Medicines's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where BeOne Medicines deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        BeOne Medicines's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        What the market is saying about BeOne Medicines

        An AI-synthesized read of the highest-engagement posts about BeOne Medicines on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See BeOne Medicines on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.